Found: 7
Select item for more details and to access through your institution.
Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 224, doi. 10.3390/vaccines9030224
- By:
- Publication type:
- Article
A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 1, p. 1, doi. 10.1371/journal.pntd.0007912
- By:
- Publication type:
- Article
A Cell Culture-Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 234, p. 1, doi. 10.1126/scitranslmed.3008761
- By:
- Publication type:
- Article
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00402-8
- By:
- Publication type:
- Article
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274906
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 19, doi. 10.1093/infdis/jiad220
- By:
- Publication type:
- Article
Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article